secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001193125-23-067520
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Reneo Pharmaceuticals says SVB exposure immaterial; accounts hold minimal cash
------------------------------------------------------------------------------

- Company maintains operating accounts at Silicon Valley Bank with minimal cash relative to total cash, cash equivalents and investments.
- Believes any loss from SVB receivership is immaterial to its financial position.
- No further details on total cash balance or contingency plans disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312523067520/0001193125-23-067520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312523067520/d481495d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-067520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer